Guardant Health CTO exercises RSUs, shares withheld
Guardant Health Chief Technology Officer Darya Chudova reported routine equity compensation activity involving restricted stock units and related tax withholding.
Rhea-AI Filing Summary
Guardant Health Chief Technology Officer Darya Chudova reported routine equity compensation activity involving restricted stock units and related tax withholding. On July 1, 2026, several restricted stock unit awards converted into common stock, reflected as multiple exercise transactions.
In connection with the vesting, 4,318 shares of common stock were retained by Guardant Health at $170.77 per share to cover her tax withholding obligations, as described in the footnotes. Following these transactions, Chudova directly held 78,373 shares of Guardant Health common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,339 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 1,667 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 3,324 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 1,700 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,339 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,667 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,324 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,700 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 4,318 | $170.77 | $737K |
Footnotes (6)
- F1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- F2. This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
- F3. Not applicable for Restricted Stock Units.
- F4. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F5. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F6. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
Key Figures
Key Terms
Restricted Stock Units financial
tax withholding obligations financial
derivative security financial
vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Guardant Health (GH) report for Darya Chudova?
What types of equity awards are involved in this Guardant Health (GH) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.